BCTX - Briacell Therapeutics Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Briacell Therapeutics Corp's activity chart (see below) currently has 5 price targets and 17 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.25% with an average time for these price targets to be met of 147 days.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 14-Oct-2025. First documented stock forecast 14-Feb-2022.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Feb-2022

$40

$36.96 (1215.79%)

1 years 17 days ago
(14-Oct-2025)

0/4 (0%)

$28.58 (250.26%)

Show more analysts

What is BCTX (Briacell Therapeutics Corp) average time for price targets to be met?

On average it took 147 days for the stock forecasts to be reached, with an average price target met ratio of 31.25%.

Which analyst most recently updated their price target on BCTX (Briacell Therapeutics Corp)?

Emily Bodnar

Which analyst has the current lower performing score on BCTX (Briacell Therapeutics Corp) with a proven track record?

EMILY BODNAR

Which analyst has the most public recommendations on BCTX (Briacell Therapeutics Corp)?

Emily Bodnar works at HC WAINWRIGHT and has 17 price targets and 18 ratings on BCTX

Which analyst is the currently most bullish on BCTX (Briacell Therapeutics Corp)?

Emily Bodnar with the highest potential upside of $36.96

Which analyst is the currently most reserved on BCTX (Briacell Therapeutics Corp)?

Emily Bodnar with the lowest potential downside of $36.94